FDA Approval for Genentech’s Subcutaneous Rituximab

News   Mar 31, 2017 | Original Story from Genentech

 
FDA Approval for Genentech’s Subcutaneous Rituximab
 
 
 
 

RELATED ARTICLES

Rare Gene Mutation Reveals How the Body Responds to the Common Cold

News

Analyzing a rare genetic mutation in a child helped researchers discover how the immune system responds to common cold viruses.

READ MORE

360 New Disease Models Identified in Lab Mouse Study

News

The research, which generated over 20 million pieces of data, has found 360 new disease models and provides 28,406 new descriptions of the genes’ effects on mouse biology and disease.

READ MORE

LifeArc, Dstl and CDRD Collaborate to Identify Antibacterial Drug Targets

News

Novel approach capitalises on commonality across pathogens.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE